Active Ingredients
(in each extended-release tablet)
Guaifenesin USP 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Aurohealth Llc for the product Guaifenesin (NDC 58602-811). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Guaifenesin USP 1200 mg
Expectorant
Do not use
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinised starch (maize)
1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST) You may also report side effects to this phone number.
Distributed by:
Aurohealth LLC.
2572 Brunswick Pike,
Lawrenceville, NJ 08648
Code: AP/DRUGS/04/2016
Made in India
AUROHEALTH
NDC 58602-811-73
Compare to the active
Ingredient in Maximum
Strength Mucinex®*
MAXIMUM STRENGTH
Guaifenesin Extended-Release Tablets 1200 mg
EXPECTORANT
Extended-Release Tablets
AUROHEALTH
NDC 58602-811-01
Compare to the active
Ingredient in Maximum
Strength Mucinex®*
MAXIMUM STRENGTH
Guaifenesin
Extended-Release Tablets 1200 mg
EXPECTORANT
14
Extended-Release
Tablets
12 HOUR
* Please review the disclaimer below.